Evidence map›Paper›PMID 41080603›Full record

ArticleFrontiers in immunology2025

Dectin-1 and dectin-2 drive protection against

Fabio Seiti Yamada Yoshikawa, Sandro Rogerio de Almeida, Shinobu Saijo

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cell surface (Amsterdam, Netherlands) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fabio Seiti Yamada YoshikawaDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Sandro Rogerio de AlmeidaSchool of Pharmaceutical Sciences, Department of Clinical e Toxicological Analysis, University of São Paulo, São Paulo, Brazil.
Shinobu SaijoDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The emerging fungal pathogen Methods: Wild-type, Dectin-1 and/or Dectin-2 knockout, and IL-17A/F knockout C57BL/6J mice were challenged with Results: We showed that the receptors are essential for host survival, necessary to limit the fungal dissemination, and that their main effector functions can be related to shaping the T cell response, notably the cytotoxic CD8+ and Treg cell populations, instead of a conventional TH17 profile. While we also observed a contribution of IL-17 in the host defense, the cytokine is not involved in the restriction of the fungal growth. Discussion: Our results uncover dectin-1 and dectin-2 as novel determinants of protection against

Indexed as

Lectins, C-TypeSporothrixSporotrichosisAnimalsCytokinesDectin-1Disease Models, AnimalInterleukin-17MiceMice, Inbred C57BLMice, KnockoutCytokinesDectin-1dectin-2, mouseInterleukin-17Lectins, C-TypeDectin-1Dectin-2IL-17Sporothrix brasiliensisTreg

Identifiers

PMID41080603
PMCPMC12507893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.